← brief for 2026-08-13 · Slowing decline

EPOGEN

Key takeaways

This trial showed EPO reduces anemia risk but not quality of life. It was a small trial with 50 patients for 6 months.

Who did this work

Amgen, Inc

Source

Paper · openFDA, renal drug labels · 2026-06-23
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5